The global demand for Surgical Aortic Valve Replacement Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Surgical Aortic valve replacement is a treatment used to repair disorders of the heart valves that control blood flow. It helps restore normal blood flow, symptom relief, life extension, and cardiac muscle function preservation. It's commonly done by open-heart surgery, which includes incising the chest or minimally invasive (MI) procedures, which entail minor incisions in the chest or a catheter implanted in the leg. When the aortic valve's function is compromised, surgical aortic valve replacement is performed. It is a process in which a non-functioning heart valve is replaced with an artificial heart valve. Major players are now introducing artificial valves constructed from carbon-coated plastic or tissue from cows, pigs, or donors.
Market Dynamics
The rising frequency of valvular illnesses, which coincides with the growing need for MIS, is one of the primary drivers driving market expansion. Moreover, the government in a number of nations are launching various initiatives to manage valvular illnesses, which is propelling the market forward. Aside from that, the expanding geriatric population is adding to market growth as valves become narrower and stiffer as they age. The market is also influenced by hospitals' favourable reimbursement practices. Furthermore, market growth is expected to be aided by an increase in the number of approvals for novel goods. This classification applies to people with severe aortic regurgitation (AR) and AR dominant mixed aortic valve disease, which can be life-threatening and debilitating.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of surgical aortic valve replacement. The growth and trends of surgical aortic valve replacement industry provide a holistic approach to this study.
Market Segmentation
This section of the surgical aortic valve replacement market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Transfemoral Approach
- Transapical Approach
- Others
By Application
- Aortic Stenosis
- Aortic Regurgitation
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Surgical Aortic Valve Replacement market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Surgical Aortic Valve Replacement Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the surgical aortic valve replacement market include Abbott, CryoLife, LivaNova, Medtronic, Edwards Lifesciences, LifeNet Health, Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
